Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Mahidol University |
---|---|
Information provided by: | Mahidol University |
ClinicalTrials.gov Identifier: | NCT00300560 |
In patients with documented ESBL-producing E.coli and Klebsiella pneumoniae will be allocated to receive colistin or conventional antibiotic regimen.
Condition | Intervention | Phase |
---|---|---|
Infections |
Drug: Colistin |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Efficacy and Safety of Colistin for Therapy of Infections Caused by Extended Spectrum Beta-Lactamase(ESBL) Producing Klebsiella Pneumoniae or Escherichia Coli |
Estimated Enrollment: | 152 |
Study Start Date: | February 2006 |
Estimated Study Completion Date: | December 2006 |
In patients with documented ESBL-producing E.coli and Klebsiella pneumoniae will be allocated to receive colistin or conventional antibiotic regimen.The primary outcome is clinical response and secondary outcomes are microbiological response and adverse events.
Ages Eligible for Study: | 18 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Visanu Thamlikitkul, MD | 662 419 7000 ext 6626 | sivth@mahidol.ac.th |
Thailand, Bangkok | |
Division of Infectious disease and Tropical Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital | Recruiting |
Bangkoknoi, Bangkok, Thailand, 10700 | |
Contact: Sunee Thanakhumtorn, RN 662 4197000 ext 6616 srstn@mahidol.ac.th | |
Principal Investigator: Visanu Thamlikitkul, MD | |
Sub-Investigator: Pornpan Koomanachai, MD | |
Sub-Investigator: Hutsaya Tantipong, MD | |
Sub-Investigator: Sriripetcharat Mekviwattanawong, MD | |
Sub-Investigator: Pasri Maharomn, MD | |
Sub-Investigator: Pinyo Rattanaumpawan, MD |
Principal Investigator: | Visanu Thamlikitkul, MD | Faculty of Medicine Siriraj Hospital |
Study ID Numbers: | SirirajCEU49-004 |
Study First Received: | March 7, 2006 |
Last Updated: | May 19, 2006 |
ClinicalTrials.gov Identifier: | NCT00300560 |
Health Authority: | Thailand: Food and Drug Administration |
ESBL-producing E.coli Infections ESBL-producing Klebsiella pneumoniae Infections Colistin |
Colistin Klebsiella Respiratory Tract Infections Respiratory Tract Diseases |
Lung Diseases Escherichia coli Infections Klebsiella Infections Pneumonia |
Anti-Infective Agents Anti-Bacterial Agents Communicable Diseases |
Therapeutic Uses Infection Pharmacologic Actions |